Technical Analysis for QTRX - Quanterix Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
33.48 | -1.70% | -0.58 |
QTRX closed down 1.7 percent on Friday, June 14, 2019, on 73 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| See historical QTRX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| New 52 Week Closing High | Bullish | -1.70% | |
| New 52 Week High | Strength | -1.70% | |
| Upper Bollinger Band Walk | Strength | -1.70% | |
| Wide Bands | Range Expansion | -1.70% | |
| Overbought Stochastic | Strength | -1.70% | |
| Up 3 Days in a Row | Strength | -1.70% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2019
- Sector: Healthcare
- Industry: Biotechnology
Quanterix is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.
Biotechnology Healthcare Life Sciences Biology Disease Inflammation Infectious Disease Biomarkers
Biotechnology Healthcare Life Sciences Biology Disease Inflammation Infectious Disease Biomarkers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more QTRX news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 34.32 |
| 52 Week Low | 12.9975 |
| Average Volume | 165,552 |
| 200-Day Moving Average | 20.9091 |
| 50-Day Moving Average | 24.3458 |
| 20-Day Moving Average | 26.5705 |
| 10-Day Moving Average | 30.398 |
| Average True Range | 1.5581 |
| ADX | 41.65 |
| +DI | 41.2817 |
| -DI | 5.9747 |
| Chandelier Exit (Long, 3 ATRs ) | 29.6457 |
| Chandelier Exit (Short, 3 ATRs ) | 25.3843 |
| Upper Bollinger Band | 35.3391 |
| Lower Bollinger Band | 17.8019 |
| Percent B (%b) | 0.89 |
| BandWidth | 66.002522 |
| MACD Line | 2.8104 |
| MACD Signal Line | 1.8805 |
| MACD Histogram | 0.9299 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 35.00 | ||||
| Resistance 3 (R3) | 35.11 | 34.71 | 34.74 | ||
| Resistance 2 (R2) | 34.71 | 34.33 | 34.66 | 34.66 | |
| Resistance 1 (R1) | 34.10 | 34.09 | 33.90 | 33.99 | 34.57 |
| Pivot Point | 33.70 | 33.70 | 33.61 | 33.65 | 33.70 |
| Support 1 (S1) | 33.09 | 33.32 | 32.89 | 32.98 | 32.39 |
| Support 2 (S2) | 32.69 | 33.08 | 32.64 | 32.30 | |
| Support 3 (S3) | 32.08 | 32.69 | 32.22 | ||
| Support 4 (S4) | 31.97 |
